Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of registration.
 SUMMARY: Mallinckrodt, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Mallinckrodt, LLC registration as a manufacturer of those controlled substances.


SUPPLEMENTARY INFORMATION:  By notice dated May 28, 2014, and published in the 
                    **Federal Register**
                     on June 3, 2014, 79 FR 31986, Mallinckrodt, LLC, 3600 North Second Street, St. Louis, Missouri 63147, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt, LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances: Controlled substance
ScheduleTetrahydrocannabinols (7370)
ICodeine-N-oxide (9053)
IDihydromorphine (9145)
IDifenoxin (9168)
IMorphine-N-oxide (9307)
INormorphine (9313)
INorlevorphanol (9634)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIMethylphenidate (1724)
IINabilone (7379)
II4-Anilino-N-phenethyl-4-piperidine (8333)
IICodeine (9050)
IIDihydrocodeine (9120)
II( print page 3985)Oxycodone (9143)
IIHydromorphone (9150)
IIDiphenoxylate (9170)
IIEcgonine (9180)
IIHydrocodone (9193)
IILevorphanol (9220)
IIMeperidine (9230)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIThebaine (9333)
IIOpium tincture (9630)
IIOpium, powdered (9639)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IIAlfentanil (9737)
IIRemifentanil (9739)
IISufentanil (9740)
IIFentanyl (9801)
II
 The company plans to manufacture the listed controlled substances for internal use and for distribution to other companies. Dated: January 9, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-01304 Filed 1-23-15; 8:45 am] BILLING CODE 4410-09-P